Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference
Press release – No. 12 / 2026 Zealand Pharma to participate in the Goldman Sachs Global Healthcare Conference Copenhagen, Denmark, June 2, 2026 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the…
Indian Pharma Companies Boost US Specialty Drug Investment Amidst Generic Market Challenges
Indian pharmaceutical companies are strategically pivoting their US market approach, deepening investments in high-value specialty drugs, complex therapies, and local manufacturing to counter pricing pressures and intensifying competition in…
Five years after its acquisition by senior management, Duchesnay Pharmaceutical Group continues to grow as one of Canada's few full-range pharma businesses
BLAINVILLE, QC, June 2, 2026 /CNW/ - Duchesnay Pharmaceutical Group (DPG) is celebrating five years of sustained growth since its acquisition by senior management in 2021, a milestone that led to the formal creation of the Group. Since the buyout…
Geode Capital Management LLC Purchases 502,582 Shares of BridgeBio Pharma, Inc. $BBIO
Geode Capital Management LLC increased its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 12.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned…
Hillsdale Investment Management Inc. Acquires 23,700 Shares of Royalty Pharma PLC $RPRX
Hillsdale Investment Management Inc. lifted its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 5,266.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission…
Geode Capital Management LLC Acquires 102,430 Shares of Royalty Pharma PLC $RPRX
Geode Capital Management LLC boosted its holdings in Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 1.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned…
Appian: Tech Platform With Margin And Cashflow Recovery Trends, Despite Q1 Net Loss (APPN)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
Nxera's Vamorolone Granted Key Regulatory Designations Supporting Faster Access for Duchenne Muscular Dystrophy Patients in South Korea
Orphan Drug Designation (ODD) recognizes Duchenne muscular dystrophy as a rare disease with significant unmet medical need without an established treatment in South Korea. Global Innovative Products on Fast Track (GIFT) designation, a priority…
UroGen settles with Teva over Jelmyto patent row (URGN:NASDAQ)
UroGen Pharma (URGN) announced on Tuesday that it reached a settlement and license agreement with Teva Pharmaceuticals (TEVA) to resolve a patent dispute over its cancer therapy Jelmyto. The dispute arose after the Israeli drugmaker sought to…
Santhera Announces Orphan Drug and Priority Review Designations for AGAMREE (Vamorolone) in South Korea
Pratteln, Switzerland, June 2, 2026 – Santhera Pharmaceuticals (SIX: SANN) today notes that AGAMREE has been granted Orphan Drug Designation (ODD) and Global Innovative Products on Fast Track (GIFT) designation by South Korea's Ministry of…
High-profile convicts lobby for rumored pardons tied to country's 250th birthday
“The President is the final decider on all pardons or commutations,” the official added. Still, the mere possibility of looming pardons has already triggered sharp interest from figures such as Martin Shkreli, whose decision to raise…
Abivax Crashes Most On Record After Cancer Cases In Trial Data Spooks Wall Street
French biotech Abivax suffered its largest intraday decline on record after reporting new data on its lead experimental inflammatory bowel disease drug, which showed cancer cases among patients in the clinical trial. The new data certainly point to…
The China Threat to… Everything
In the 1980s and ‘90s, China was among the poorest countries in the world. More than 90% of the country's population lived in extreme poverty in the early ‘80s. In one of the most remarkable growth stories in history, the country has…
China's biotech boom alarms Western lawmakers, investors
China's ascendance in biotech is raising alarm bells among some lawmakers and investors in the West. Eli Lilly entered into its latest agreement with a Chinese drugmaker Monday, while Pfizer last week announced a tie-up with a Chinese firm to…
10 companies actively recruiting for roles in future health
If you are a professional looking for your next opportunity in the growing future health space, consider one of the following 10 companies. When it comes to careers in future health, there are an array of exciting opportunities for professionals…
Receive a Daily briefing on Pharma Industry News
Get Started